Document and Entity Information Document Information [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Class A [Member] Series A Common Stock Common Class B [Member] Series B Common Stock Document Information [Line Items] Document information Document Type Document Annual Report Document Period End Date Document Fiscal Year Focus Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Period Focus Amendment Flag Auditor Name Auditor Location Auditor Firm ID Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalent Cash and cash equivalents Marketable Securities, Current Short-term marketable securities Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total prepaid expenses and other current assets Assets, Current Total current assets Marketable Securities, Noncurrent Long-term marketable securities Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Operating Lease, Liability, Current Operating lease liabilities Liabilities, Current Total current liabilities Commitments and Contingencies Commitments and contingencies Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Undesignated preferred stock, $0.0001 per share: 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2025 and December 31, 2024 Common Stock, Value, Issued Common stock Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Equity, Attributable to Parent Ending balance Beginning balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Ending balance (in shares) Beginning balance (in shares) Common stock, shares outstanding Statement of Comprehensive Income [Abstract] Operating Expenses [Abstract] Operating expenses: Research and Development Expense External research and development expenses Research and development expenses General and Administrative Expense External General and administrative expenses General and administrative expenses Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income : Interest and Other Income Interest income and other, net Other Nonoperating Income (Expense) Total other income Net loss Net loss Earnings Per Share, Basic Net loss per share, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted-average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares outstanding, diluted (in shares) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income: OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Net unrealized gain (loss) on marketable securities Unrealized loss on marketable securities Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive loss Statement of Stockholders' Equity [Abstract] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common stock Additional Paid-in Capital [Member] Additional paid-in capital Retained Earnings [Member] Accumulated deficit AOCI Attributable to Parent [Member] Accumulated Other Comprehensive (Loss) Income Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) In Stockholders' Deficit Amount of shares reclassified as common stock to series A common stock. Stock Issued During Period Value Reclassification Conversion of Series B common stock to Series A common stock Number of shares reclassified as common stock to series A common stock. Stock Issued during Period, Shares Reclassification Conversion of Series B common stock to Series A common stock (in shares) Stock Issued During Period, Value, New Issues Sale of Series A common stock, net of issuance costs Stock Issued During Period, Shares, New Issues Shares issued (in shares) Sale of Series A common stock, net of issuance costs (in shares) Stock Issued During Period, Value, Stock Options Exercised Issuance of Series A Common Stock upon exercise of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Options exercised Issuance of Series A Common Stock upon exercise of stock options (in shares) Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Issuance of Series A Common Stock for vesting of restricted stock units Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Issuance of Series A Common Stock for vesting of restricted stock units (in shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense Payments of Stock Issuance Costs Issuance costs Statement of Cash Flows [Abstract] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Accretion (Amortization) of Discounts and Premiums, Investments Accretion of discount on marketable securities Amount of non-cash operating lease expenses. Non Cash Operating Lease Expenses Non-cash operating lease expense Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Amount of deferred financing costs written off in the current period. Deferred Financing Costs Written Off Write-off of deferred financing costs Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable, accrued expenses and other current liabilities Increase (Decrease) in Operating Lease Liability Operating lease liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities Payments to Acquire Marketable Securities Purchases of marketable securities Proceeds from Sale and Maturity of Marketable Securities Sales and maturities of marketable securities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash provided by (used in) investing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities Proceeds from Issuance of Common Stock Proceeds from sale of Series A common stock, net of issuance costs Payments of Financing Costs Payment of financing costs Proceeds from Stock Options Exercised Proceeds from exercise of stock options Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Supplemental Cash Flow Information [Abstract] Supplemental non-cash investing and financing activities: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use assets obtained in exchange for operating lease obligations Change in operating lease liability Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Deferred financing costs within accounts payable and accrued expenses Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Description of Business and Basis of Presentation Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Significant Accounting Policies Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements and Fair Value of Financial Instruments Prepaid Expense and Other Assets, Current [Abstract] Other Current Assets [Text Block] Prepaid Expenses and Other Current Assets Accrued Liabilities and Other Liabilities [Abstract] Other Liabilities Disclosure [Text Block] Accrued Expenses and Other Current Liabilities Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders' Equity Note [Abstract] Equity [Text Block] Stockholders' Equity Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Income Taxes Segment Reporting [Abstract] Segment Reporting Disclosure [Text Block] Segment Reporting Basis of Accounting, Policy [Policy Text Block] Basis of presentation Disclosure of emerging growth company status accounting policy. Emerging Growth Company Status, Policy [Policy Text Block] Emerging growth company status Disclosure of accounting policy related to a going concern assumption. Going Concern, Policy [Policy Text Block] Liquidity Earnings Per Share, Policy [Policy Text Block] Net loss per share attributable to common stockholders Segment Reporting, Policy [Policy Text Block] Segment information Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of credit risk Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents Marketable Securities, Policy [Policy Text Block] Marketable securities Lessee, Leases [Policy Text Block] Leases Research and Development Expense, Policy [Policy Text Block] Accrued research and development expense Disclosure of accounting policy common stock warrants. Common Stock Warrants [Policy Text Block] Common stock warrants Share-Based Payment Arrangement [Policy Text Block] Stock-based compensation expense Income Tax, Policy [Policy Text Block] Income taxes Foreign Currency Disclosure [Text Block] Foreign currency translation New Accounting Pronouncements, Policy [Policy Text Block] New accounting pronouncements not yet adopted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted loss per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially dilutive securities Debt Securities, Available-for-Sale [Table Text Block] Schedule of marketable securities, available-for-sale Schedule of Other Current Assets [Table Text Block] Schedule of prepaid expenses and other current assets Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of future maturities of operating lease liabilities Lease, Cost [Table Text Block] Schedule of supplemental lease information Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stock-based compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock-based compensation expense Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of option activity transactions Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Schedule of restricted stock unit activity Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of fair value assumptions Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Summary of net loss reconciliation Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Sale of Stock [Axis] Sale of Stock [Domain] IPO [Member] IPO Represents information related to follow-on offering (FPO). Follow-On Public Offering [Member] FPO Represents information related to 2024 At-The-Market (ATM) Offering sales agreement. At The Market Offering 2024 [Member] 2024 ATM Offering Represents information related to 2025 At-The-Market (ATM) Offering sales agreement. At The Market Offering 2025 [Member] 2025 ATM Offering Subsidiary, Sale of Stock [Line Items] Organization and description of business Cash, Cash Equivalents, and Short-Term Investments Cash and cash equivalents and marketable securities Shares Issued, Price Per Share Share price (in dollars per share) Sale of Stock, Consideration Received on Transaction Net proceeds Total value of shares that may be sold under the stock sales arrangement. Stock Sales Arrangement, Maximum Value Of Shares Maximum value of sales under the arrangement Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Net loss per share Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Denominator: Earnings Per Share [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Stock options Warrant [Member] Warrants Restricted Stock Units (RSUs) [Member] Restricted Stock Units Restricted stock units Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive securities (in shares) Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Represents information relating to Series A common stock warrants Series A Common Stock Warrants [Member] Redeemable convertible preferred stock Series A common stock warrant Fair Value Measurement Inputs and Valuation Techniques [Line Items] Redeemable Convertible Preferred Stock Warrant Liability Class of Warrant or Right, Outstanding Warrants issued (in shares) Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrant (in dollars per share) Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Fair Value, Recurring [Member] Recurring Asset Class [Axis] Asset Class [Domain] Represents the information pertaining short-term marketable securities. Short-term marketable securities [Member] Short-term Represents the information pertaining Long-term marketable securities. Long-term marketable securities [Member] Long-term Measurement Basis [Axis] Portion at Fair Value Measurement [Member] Reported Value Measurement [Member] Amortized cost Estimate of Fair Value Measurement [Member] Estimated Fair Value Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 2 [Member] Level 2 Financial Instrument [Axis] Financial Instruments [Domain] Money Market Funds [Member] Money market funds Commercial Paper [Member] Commercial paper Corporate Debt Securities [Member] Corporate debt securities US Treasury Securities [Member] U.S. Treasury securities US Government Agencies Debt Securities [Member] Agency securities Asset-Backed Securities [Member] Asset-backed securities Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair value on a recurring basis Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents fair value Investments, Fair Value Disclosure Marketable securities Assets, Fair Value Disclosure Total assets fair value Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized Losses Debt Securities, Available-for-Sale, Term Expected maturity term Amount of prepaid clinical expenses current. Prepaid Clinical Expenses Current Prepaid clinical expenses Amount of asset related to consideration paid in advance for research and development that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Prepaid Research And Development Prepaid research and development Prepaid Insurance Prepaid insurance Deferred Costs, Current Deferred financing costs Other Assets, Current Other Employee-related Liabilities, Current Accrued payroll-related costs Amount of accrued clinical costs current. This amount is expected to be consumed within one year or the normal operating cycle, if longer. Accrued Clinical Costs Current Accrued clinical costs Amount of accrued research liability current. This amount is expected to be consumed within one year or the normal operating cycle, if longer. Accrued Research Liability, Current Accrued research and development costs Amount of current accrued general and administrative costs. This amount is expected to be consumed within one year or the normal operating cycle, if longer. Accrued General & Administrative Costs, Current Accrued general and administrative costs Other Liabilities, Current Other Loss Contingencies [Table] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Represents the information pertaining to Ascletis BioScience Co. Ltd, a subsidiary of Ascletis Pharma Inc. (Ascletis Pharma), biotechnology company incorporated in the Cayman Islands and headquartered in Hangzhou, China and a Company investor. Ascletis BioScience Co. Ltd [Member] Ascletis Loss Contingencies [Line Items] Commitments and contingencies Amount of maximum aggregate development and commercial milestone payments eligible to receive. Maximum Aggregate Development and Commercial Milestone Payments Eligible to Receive Maximum eligible development and commercial milestone payments Other Commitment Committed amount, CMO Term Sheet Lessee, Operating Lease, Term of Contract Operating lease term Net Rentable Area Rented area (in square feet) Amount of operating lease payments per month. Operating Lease Payments Per Month Monthly lease payments Operating Lease, Cost Operating lease cost Lessee, Operating Lease, Liability, to be Paid, Year One 2026 Lessee, Operating Lease, Liability, to be Paid Total lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: present value discount Operating Lease, Liability Present value of lease liabilities Cash Flow, Operating Activities, Lessee [Abstract] Cash flow information Operating Lease, Payments, Use Operating cash flows from operating leases Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Discount rate Stock, Class of Stock [Table] Schedule of Stock by Class [Table] Plan Name [Axis] Plan Name [Domain] Represents the information pertaining to 2023 Employee Stock Purchase Plan. Employee Stock Purchase Plan 2023 [Member] 2023 Employee Stock Purchase Plan Class of Stock [Line Items] Stockholders' deficit Represents the conversion of class B common stock to Class A subject to specified percentage of shares of class A Common stock held. Common Stock, Class Conversion, Beneficial Ownership, Percentage of Stock Held Beneficial ownership stock held (as a percent) Common Stock, Capital Shares Reserved for Future Issuance Common stock reserved for future issuance (in shares) Represents the information pertaining to Equity Incentive Plan 2023. Equity Incentive Plan 2023 [Member] 2023 Equity incentive plan Represents the information pertaining to Inducement grants granted outside of the 2023 Plan. Inducement Grants Outside of 2023 Plan [Member] 2024 Inducement Grants Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Annual increase in reserved shares (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Increase in future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Contractual term Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] General and Administrative Expense [Member] General and administrative Research and Development Expense [Member] Research and development Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-based compensation Share-Based Payment Arrangement, Expense Total stock-based compensation Represents the information pertaining to time-based stock options. Time Based Stock Options [Member] Time-based options Represents the information pertaining to performance-based stock options. Performance-Based Stock Options [Member] Performance-based options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Balance at the end Balance at the beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Options forfeited/expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable at the end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Balance at the end (in dollars per share) Balance at the beginning (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Options forfeited/expired (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at the end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Term and Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted- Average Remaining Contractual Term, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term - Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted- Average Remaining Contractual Term, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Aggregate Intrinsic Value - Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value - Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value options exercised Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Total unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation cost remaining period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Balance at the end (in shares) Balance at the beginning (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested/released (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average grant date fair value, ending (in dollars per shares) Weighted average grant date fair value, beginning (in dollars per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value, granted (in dollars per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value, vested (in dollars per share) Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] Reconciliation of the provision for income taxes, amount Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Federal income taxes at statutory rates, amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount Research and development credits, amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Stock-based compensation, amount Effective Income Tax Rate Reconciliation, Tax Contingency, Amount Changes in unrecognized tax benefits, amount Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense related to Section 162(m) limitations. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Section 162(M) Limitations, Amount Section 162(m) limitations, amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Other, amount Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Change in valuation allowance, amount Income Tax Expense (Benefit) Effective income tax rate, amount Tax Jurisdiction of Domicile [Extensible Enumeration] Effective Income Tax Rate Reconciliation, Percent [Abstract] Reconciliation of the provision for income taxes, in percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Federal income taxes at statutory rates, percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent Research and development credits, percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Stock-based compensation, percent Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Changes in unrecognized tax benefits, percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for Section 162(m) limitations. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Section 162(M) Limitations, Percent Section 162(m) limitations, percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Other, percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance, percent Effective Income Tax Rate Reconciliation, Percent Effective income tax rate, percent Deferred Tax Assets, Net of Valuation Allowance [Abstract] Deferred tax assets: Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carryforwards Amount of deferred tax asset attributable to taxable temporary differences from Capitalized start-up costs and research expenses. Deferred Tax Assets, Capitalized Start Up Costs And Research Expenses Capitalized start-up costs and research expenses Deferred Tax Asset, In-Process Research and Development Research and development credits Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Accruals, reserves and other Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Stock compensation Amount of deferred tax asset attributable to taxable temporary differences from leasing arrangements. Deferred Tax Assets, Leasing Arrangements Lease liabilities Deferred Tax Assets, Gross Total gross deferred assets Deferred Tax Assets, Valuation Allowance Valuation allowance Deferred Tax Assets, Net of Valuation Allowance Total deferred tax assets Deferred Tax Liabilities, Gross [Abstract] Deferred tax liabilities: Deferred Tax Liabilities, Leasing Arrangements Right-of-use assets Deferred Tax Liabilities, Net Total deferred liabilities Deferred Tax Assets, Net Net deferred tax assets Operating Loss Carryforwards [Table] Income Tax Jurisdiction [Axis] Income Tax Jurisdiction [Domain] Domestic Tax Jurisdiction [Member] Federal State and Local Jurisdiction [Member] State Operating Loss Carryforwards [Line Items] Income taxes Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Change in valuation allowance Operating Loss Carryforwards Operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Operating loss carryforward subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Operating loss carryforward not subject to expiration Tax Credit Carryforward, Amount Tax credit carryforwards Unrecognized Tax Benefits [Roll Forward] Schedule of reconciliation of the unrecognized tax benefits Unrecognized Tax Benefits Unrecognized tax benefits as of the end of the year Unrecognized tax benefits as of the beginning of the year Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Decrease related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Increase related to current year tax positions Unrecognized Tax Benefits that Would Impact Effective Tax Rate Unrecognized tax benefit impacting effective tax rate Unrecognized Tax Benefits, Interest on Income Taxes Accrued Accrued interest related to uncertain tax positions Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Entity's single operating segment. Single Reportable Segment [Member] Operating segment Product and Service [Axis] Product and Service [Domain] Product [Member] Represents information related to Denifanstat. Denifanstat [Member] Denifanstat Represents information related to TVB-3567. T V B-3567 [Member] TVB-3567 Segment Reporting Information [Line Items] Segment Reporting Number of Operating Segments Number of operating segments Number of Reportable Segments Number of reportable segments Labor and Related Expense Personnel costs Segment Reporting, Other Segment Item, Amount Other segment items